Search by Drug Name or NDC
NDC 68817-0134-50 ABRAXANE 100 mg/20mL Details
ABRAXANE 100 mg/20mL
ABRAXANE is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Abraxis BioScience, LLC. The primary component is PACLITAXEL.
MedlinePlus Drug Summary
Paclitaxel (with albumin) injection is used to treat breast cancer that has spread to other parts of the body and has not improved or worsened after treatment with other medications. Paclitaxel (with albumin) injection is also used in combination with other chemotherapy medications to treat non-small cell lung cancer (NSCLC). Paclitaxel (with albumin) injection is used in combination with gemcitabine (Gemzar) to treat cancer of the pancreas. Paclitaxel is in a class of medications called antimicrotubule agents. It works by stopping the growth and spread of cancer cells.
Related Packages: 68817-0134-50Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Paclitaxel (with albumin) Injection
Product Information
| NDC | 68817-0134 |
|---|---|
| Product ID | 68817-134_25a98542-1909-490d-b162-6e36d3997d8a |
| Associated GPIs | 21500012201920 |
| GCN Sequence Number | 058624 |
| GCN Sequence Number Description | paclitaxel protein-bound VIAL 100 MG INTRAVEN |
| HIC3 | V1F |
| HIC3 Description | ANTINEOPLASTICS,MISCELLANEOUS |
| GCN | 24094 |
| HICL Sequence Number | 026856 |
| HICL Sequence Number Description | PACLITAXEL PROTEIN-BOUND |
| Brand/Generic | Brand |
| Proprietary Name | ABRAXANE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Paclitaxel |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/20mL |
| Substance Name | PACLITAXEL |
| Labeler Name | Abraxis BioScience, LLC |
| Pharmaceutical Class | Microtubule Inhibition [PE], Microtubule Inhibitor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA021660 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68817-0134-50 (68817013450)
| NDC Package Code | 68817-134-50 |
|---|---|
| Billing NDC | 68817013450 |
| Package | 1 VIAL, SINGLE-USE in 1 CARTON (68817-134-50) / 20 mL in 1 VIAL, SINGLE-USE |
| Marketing Start Date | 2005-02-10 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |